Fortive ( FTV Quick Quote FTV - Free Report) reported first-quarter 2021 earnings of 63 cents per share, which outpaced the Zacks Consensus Estimate by 6.8% and increased 37% year over year. Sales increased 13.6% year over year to $1.26 billion and beat the consensus mark by 2.9%. Quarter Detail
Intelligent Operating Solutions segment generated revenues of $510.9 million (accounting for 40.6% of total first-quarter revenues), which increased 9.5% on a year-over-year basis.
Precision Technologies segment generated revenues of $447.4 million (35.5% of total revenues), which increased 14.3% year over year.
Advanced Healthcare Solutions segment generated revenues of $300.9 million (23.9% of total revenues), which increased 20.3% year over year.
Gross margin came in at 56.5%, which expanded 130 basis points (bps) year over year. Selling, General and Administrative (SG&A) expenses were $428.1 million, reflecting a 3% year-over-year increase. As a percentage of revenues, SG&A expenses decreased 350 bps year over year. Research and development (R&D) expenses were $86.2 million, up 6.7% year over year. As a percentage of revenues, R&D expenses decreased 40 bps year over year. Operating margin was 15.7%, which expanded 530 bps on a year-over-year basis. Segment wise, operating margin from Intelligent Operating Solutions came in at 21.2%, which expanded 380 bps year over year. Precision Technologies operating margin came in at 21.4%, up 270 bps on a year-over-year. Advanced Healthcare Solutions’ operating income was $18.9 million against loss of $15.8 million in the year-ago quarter. Free Cash Flow
Fortive reported free cash flow of $144 million, up 50% year over year in first-quarter 2021.
For the second quarter of 2021, Fortive expects adjusted net earnings in the range of 56-60 cents per share. The Zacks Consensus Estimate for the quarter is pegged at 59 cents per share.
Core growth is expected between 16-19%. Adjusted operating profit is expected between roughly 19.5% and 20.5%. For 2021, Fortive expects adjusted net earnings in the range of $2.50-$2.60 per share. The consensus mark for the same is pegged at $2.75 per share. Core growth is expected between 7-10%, driven by continued strong momentum across core industrial end markets. Moreover, volume improvement of elective procedure is expected to drive Advanced Healthcare Solutions’ top-line growth. Adjusted operating profit is expected between roughly 22% and 23%. Zacks Rank & Other Stocks to Consider
Fortive currently has a Zacks Rank #2 (Buy).
Similar-ranked stocks in the broader technology sector are CDW Corporation ( CDW Quick Quote CDW - Free Report) , Cognex ( CGNX Quick Quote CGNX - Free Report) and EPAM Systems ( EPAM Quick Quote EPAM - Free Report) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. CDW is set to report quarterly earnings on May 5. Both Cognex and EPAM are scheduled to report the same on May 6. 5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Today, See These 5 Potential Home Runs >>